Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00477984
Other study ID # 06-221/O
Secondary ID
Status Completed
Phase N/A
First received May 23, 2007
Last updated April 11, 2008
Start date May 2007
Est. completion date March 2008

Study information

Verified date April 2008
Source Utrecht Institute for Pharmaceutical Sciences
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

Previous studies have shown that alcohol significantly impairs driving performance. Acute alcohol administration also has a detrimental effect on secondary task performance during dual-tasks. The present study will investigate the effects of five different dosages of ethanol (0,0.2, 0,5, 0,8 and 1,0 % BAC) on performance in a driving simulator. Steering performance and brain activity will be recorded in both single- and dual-task conditions.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date March 2008
Est. primary completion date March 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 21 Years to 50 Years
Eligibility Inclusion Criteria:

- He/she is aged between 21-50

- Written informed consent

- Right-handed

- Normal static binocular acuity, corrected or uncorrected

- Normal hearing

- Social Drinker (average of 7 to 21 alcoholic drinks per week)

- Possession of a drivers license

- Be considered as reliable and mentally capable of adhering to the protocol.

Exclusion Criteria:

- Current drug use (positive urine drug screen on the presence of amphetamines (including MDMA), barbiturates, cannabinoids, benzodiazepines, cocaine, and opiates)

- Positive urine pregnancy drug screen in women

- Use of psychoactive medication

- Positive alcohol breath test

- Prior enrolment in the same study

- Physical or mental illness

- Excessive alcohol use (>21 alcoholic drinks per week)

- Excessive smoking (more than 10 cigarettes per day)

- Intake of caffeine-containing beverages over 5 glasses per day

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Drug:
alcohol
alcohol(0.02%, 0.05%, 0.08% and 0.10%) and placebo

Locations

Country Name City State
Netherlands Utrecht Institute for Pharmaceutical Sciences Utrecht

Sponsors (1)

Lead Sponsor Collaborator
Utrecht Institute for Pharmaceutical Sciences

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary parameter of the steering simulator is the standard deviation of the car from the center of the road (steering error). 5 testdays No
Secondary Reaction speed after hearing the deviant target tone. Brain activity: ERPs of interest are the mismatch negativity (MMN), P3a, P3b, and reorienting negativity (RON) 5 testdays No
See also
  Status Clinical Trial Phase
Recruiting NCT05054738 - CRP and S&A for Inpatient Veterans N/A
Completed NCT02233738 - Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT00536146 - The Stress-Hormone System in Alcohol-Dependent Subjects N/A
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02939352 - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues Early Phase 1
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01389297 - Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery N/A
Completed NCT00768508 - Combined Pharmacotherapies for Alcoholism Phase 3
Completed NCT01113164 - Matching Genotypes and Serotonergic Medications for Alcoholism Phase 1
Completed NCT01760785 - Valproate for Mood Swings and Alcohol Use Following Head Injury N/A
Completed NCT00127231 - Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women N/A
Terminated NCT02842528 - Cognitive Vulnerability Factors in Alcohol-dependence N/A
Completed NCT00367575 - An Internet-based Intervention for Problem Drinking N/A
Completed NCT00167687 - Prazosin Alcohol Dependence IVR Study Phase 4
Completed NCT00583440 - 12-step Facilitation for the Dually Diagnosed Phase 1/Phase 2
Completed NCT00223639 - New Medications to Treat Alcohol Dependence Phase 2